Arthralgia and blood culture-negative endocarditis in middle Age Men suggest tropheryma whipplei infection: report of two cases and review of the literature by Anthony Alozie et al.
CASE REPORT Open Access
Arthralgia and blood culture-negative
endocarditis in middle Age Men suggest
tropheryma whipplei infection: report of
two cases and review of the literature
Anthony Alozie1*, Annette Zimpfer2, Kerstin Köller3, Bernd Westphal1, Annette Obliers2, Andreas Erbersdobler2,
Gustav Steinhoff1 and Andreas Podbielski3
Abstract
Background: Whipple’s disease is a rare, often multisystemic chronic infectious disease caused by the rod-shaped
bacterium Tropheryma whipplei. Very rarely the heart is involved in the process of the disease, leading to culture-
negative infective endocarditis. Up to 20 % of all infective endocarditis are blood culture-negative and therefore a
diagnostic challenge. We present two unusual cases of culture-negative infective endocarditis encountered in two
different patients with prior history of arthralgia. A history of rheumatic arthritis or even a transient arthralgia should
put Tropheryma whipplei on the top of differentials in patients of this age group presenting with culture-negative
infective endocarditis, especially in cases of therapy resistance to antirheumatic agents.
Case presentation: The first patient was a 55 year-old Caucasian male with culture-negative Whipple-related
adhesive pericarditis and endocarditis of the aortic valve. Importantly, the patient reported a 15-year history of
therapy resistant sero-negative migratory polyarthritis. Aortic valve endocarditis developed during treatment with
tocilizumab. The second patient was a 65-year-old male patient with no prior history of the classic Whipple’s
disease who presented with a culture-negative aortic valve endocarditis. His past medical history revealed episodes
of transient arthralgia, which he was not treated for however, due to the self-limiting nature of the symptoms. Both
patients underwent aortic valve replacement surgery. During surgery, pericardectomy was necessary in the first
patient due to adhesive pericarditis. Post surgery both patients were started on long-term treatment with
trimetoprim-sulfamethoxazol. At 1-year follow-up of both patients, echocardiographic and clinical assessment
revealed no signs of persistent infection. Both men reported negative history of arthralgia during the one year
period post surgery.
Conclusion: Tropheryma whipplei culture negative-infective endocarditis is an emerging clinical entity,
predominantly found in middle-aged and older men with a history of arthralgia. These data highlight the need
for ruling out Whipple’s disease in patients with a history of arthralgia prior to initiation of biological agents in
treatment of rheumatoid arthritis. There is also a need to assess for Tropheryma whipplei in all patients with
culture- negative infective endocarditis.
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Background
Whipple’s disease is a rare, often multisystemic chronic
infectious disease caused by the rod-shaped bacterium
Tropheryma whipplei [1]. A symptomatic disease only
develops in patients with partially defined immunologic
defects, i.e., Th1/Th2-imbalances [2]. The disease clas-
sically manifests with diarrhea, weight-loss and ar-
thropathy. Cardiac involvement is rarely part of the
primary syndrome [3]. Blood cultures may be negative
in Whipple’s endocarditis [4]. Other manifestations of
Whipple’s disease are frequently absent in patients
with Whipple’s endocarditis [4]. However, with the
availability of molecular diagnostic tools such as poly-
merase chain reaction (PCR), more cases are increas-
ingly recognized [5, 6]. The increased recognition rate
led to the insight that Whipple’s endocarditis can occur
without other classical manifestations of Whipple’s disease
[4]. In Germany, the reported incidence rate for T. whip-
plei endocarditis is about 6 % of all infectious cases: T.
whipplei was the fourth most frequent pathogen found
among 255 cases of endocarditis with an etiologic diagno-
sis and was the most common pathogen associated with
blood culture–negative endocarditis [19].
Case presentation
Case 1
A 55-year old Caucasian male presented with progres-
sive muscle weakness, unintended weight-loss over a
period of 6 months, malaise and exercise dependent dys-
pnea over a period of 4 weeks. He denied fever or chills
but reported episodic light-headedness and shortness of
breath. Holter ECG revealed intermittent second and
third degree atrio ventricular block. Significant in his
past medical history was a 15-year intermittent joint
swelling and early morning stiffness, affecting predomin-
antly both ankle joints and the wrists, which led to the
diagnosis of sero-negative rheumatoid arthritis. Thera-
peutic trials with different antirheumatic agents including
Methotrexate, Adalimumab, Cyclosporin A, Etanercept
and lastly Tocilizumab did not lead to any sustainable
remission. Prior to diagnosis of aortic valve endocarditis
he was receiving 10 mg prednisolon orally daily, with
moderate success. A positive quantiferon-TB test was re-
ported 1 year prior to current admission. At that time,
despite lacking clinical signs of active tuberculosis, Isonia-
zid and Rifampicin therapy was initiated, but stopped
shortly thereafter due to severe adverse effects on the pa-
tient. Until the current admission, he remained without
obvious clinical signs of active tuberculosis.
Complete laboratory panels on admission revealed
C-reactive protein 90 mg/l, leucocytes count 13 × 10 9/l
and procalcitonin 0.11 g/l. No anemia or elevated markers
of myocardial ischemia and liver pathology were apparent.
On physical examination, a 3/6 early diastolic decrescendo
murmur best heard at the left intercostal space was appre-
ciated. A chest radiograph showed mild cardiomegaly and
pulmonary edema. Transthoracic and transesophageal
echocardiograms demonstrated 13 × 10 mm mobile aortic
valve vegetations on the ventricular surface of the aortic
valve and severe aortic regurgitation (Fig. 1a). Because of
six negative blood cultures, a presumptive diagnosis of
culture-negative aortic and mitral valve endocarditis was
made and empiric antibiotic therapy with ampicillin/sul-
bactam and gentamycin was started. Expedited indication
for aortic valve replacement surgery was made and the
patient was transferred to the heart surgery unit for oper-
ation, which was carried out 2 days later.
He underwent tissue aortic valve replacement and
intrasurgical transaortic direct visualization of the mitral
valve. The mitral valve was merely mildly degenerative
but competent and without evidence of endocarditis.
After sternotomy, the pericardial tissue was found to be
predominantly adherent to the epicard, requiring exten-
sive adhesiolysis before installation of the heart lung
machine. The aortic valve was severely degenerated and
calcified. At first, no macroscopic evidence of endocardi-
tis was noticed. However, free floating vegetation was vi-
sualized on the subvalvular surface of the aortic valve
attached between the left and right commissural junction.
Specimens from both the aortic valve and pericardium
were taken for microbiological and histopathological ana-
lysis. Otherwise, surgery progressed without complications
and the patient was transferred to the intensive care unit
for overnight monitoring.
The antibiotic treatment regimen was complemented
with vancomycin and rifampicin prior to surgery and was
continued until the fourth post surgical day. Polymerase
chain reaction (PCR) results revealed Tropheryma whipplei
as the causative agent. This was confirmed by histopatho-
logical visualization of PAS and CD-68 positive macro-
phages on both aortic and pericardial tissues (Fig. 1b–d). A
diagnosis-adapted scheme of the antibiotic regimen was
immediately installed, comprising ceftriaxon (4 weeks),
meropenem (14 days), and Trimethoprim/Sulfamethoxa-
zol, which was to be continued for 1–2 years depending
on clinical and paraclinical response to this therapy
regimen. In-hospital stay was prolonged due to persistent
grade III° atrial ventricular block necessitating transvenous
implantation of a DDD-pacemaker on the 7th post-
surgical day. Then, the patient was transferred to a
neighboring primary care center for further intravenous
antibiotic treatment and monitoring before starting three
weeks of rehabilitation.
At one-year follow-up, prednisolon dosage has been
tapered and therapy terminated, without current clinical
evidence of active arthritis. Regular echocardiographic
and clinical evaluation remained stable and positive ex-
cept for a persistent CRP values ranging between 10 and
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25 mg/l but normal leucocytes. Gastroenteroscopic biopsy
analysis revealed no evidence of persistent Whipple’s dis-
ease. Continued regular echocardiographic and clinical
check-ups remain imperative for this patient.
Histopathology
Histologic examination of the resected aortic valve
showed a severely degenerative calcific valvular disease
with a chronic resorptive inflammation and superficial
chronic erosions and ulcerations (Fig. 1b). With PAS re-
agent, foamy macrophages with granular intracellular
PAS positive material, characteristic of T. whipplei infec-
tion, were demonstrated (Fig. 1c). Separately submitted
pericardial tissue showed a severely sclerosed pericar-
dium with multiple calcifications (Fig. 1d). There was
only a mild chronic inflammation present, but foamy
macrophages with typical PAS-positive inclusions in-
dicating the presence of T. whipplei could also be
demonstrated.
Microbiology
Processing of blood cultures followed the established
standards of the German Society for Hygiene and Micro-
biology (DGHM). The microbiology laboratory of the
Rostock University Medicine is accredited according to
DIN EN ISO 15183 for these tests as well as for the
subsequently described PCR examinations. DNA extrac-
tion was performed with the Qiagen DNA Mini Kit
(QIAGEN, Hilden, Germany) according to the manufac-
turer’s protocol. Nucleic acid concentration was mea-
sured using a biophotometer (Eppendorf, Hamburg,
Germany). For 16S rDNA PCR primers 16S8_27 and
16S_907 and polymerase moltaq (molzym) was utilized
[7, 8]. The following reaction conditions were chosen: (i)
15 min at 94 °C; (ii) 30x [1 min at 94 °C, 1 min at 50 °C,
1 min at 72 °C]; (iii) 5 min at 72 °C [7, 8]. PCR products
were determined by gel electrophoresis, purified with
the NAT CLEAN-UP/NUCLEOSPIN® EXTRACT II
(Machery-Nagel, Düren, Germany) and subsequently
sent to Microsynth Sequencing Device (Göttingen,
Germany) for the actual sequencing reaction. Sequence
analysis was performed using NCBI nucleotide blast
search (http://www.ncbi.nlm.nih.gov), resulting in identi-
fication of T. whipplei.
Case 2
A 65-year- old male patient presented to his family
physician for routine check-up with feelings of exhaus-
tion over the previous 2- months, mild exercise induced
dyspnea and occasional palpitations. On cardiac auscul-
tation a 2/6 early diastolic decrescendo murmur best
heard at the third left intercostals space radiating along
Fig. 1 a–d: Whipple endocarditis and pericarditis in a 55-year old patient. a. TEE showing a severe degenerative aortic valve and aortic valve
vegetations with aortic regurgitation III°. b. Severely degenerative and calcific aortic disease with chronic ulcerations (Pas, 2x, inset: hematoxillin&eosin,
2x). *labels the area visualized in 1C. c. Demonstration of Pas-reactive foamy macrophages, which contained T. whipplei particles. Note:
the macrophages are seen in relation to capillaries (Pas, 100x, inset: Pas, 10x). d. Pericardium with extensive sclerosis and calcification
(hematoxillin&eosin, 2x)
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the left sternal border was appreciated. He reported
yearly travel to Denmark and Sweden for the purpose of
holidays, but denied any close contact to livestock, pets
or poultry. Laboratory test on admission revealed 9 × 10
[9]/L white blood cells, 31 mg/l c-reactive protein and
0.074 ng/ml procalcitonin respectively. All other labora-
tory values including haemoglobin, liver and renal pa-
rameters were within normal range. A chest x-ray film
revealed bilateral accentuated perihilar haze and mild
cardiomegaly. Abdominal sonography only revealed a
mild splenomegaly. Transthoracic echocardiographic
exploration revealed 1 cm × 1 cm vegetation over aortic
surface of the aortic valve (Fig. 2a–b). Aortic regurgita-
tion grade III° with reduced left ventricular ejection frac-
tion (40 %) was also appreciated. He was started on a
triple antibiotic combination of Rifampicin (2 × 600 mg
i.v., Gentamicin i.v. according to blood levels and Sulbac-
tam/Ampicilin 2 × 3 g i.v.). Two sets of blood cultures
remained negative. During surgery for aortic valve re-
placement, all valve leaflets with exception of the valve
ring were involved in the endocarditic process, with severe
destruction of all valves. Indication for a 21 mm trifecta
tissue valve (St Paul, Minn) was made after excision of the
diseased valve. Post surgery the patient was transferred to
the ICU and after an uncomplicated ICU stay he was
transferred to the normal ward. Further hospitalisation
was uncomplicated and the patient was discharged to our
cardiology unit on the 7th day post surgery. Polymerase
chain reaction (PCR) results 10 days post surgery revealed
Tropheryma whipplei as the causative agent. This was
confirmed by histopathological visualization of Periodic
Acid Schiff (PAS) and CD-68 positive macrophages on the
aortic tissues (Fig. 2c–d). A diagnosis-adapted scheme of
the antibiotic regimen was immediately installed com-
prising ceftriaxon (4 weeks), meropenem (14 days), and
Trimethoprim/Sulfamethoxazol, which was to be con-
tinued for 2 years depending on clinical and paraclinical
response to this therapy regimen. At 6-month- follow up,
echocardiographic and clinical evaluation remained stable
with normal infective parameters. During the six-month
follow- up post surgery, the patient revealed that prior to
his hospitalization for endocarditis treatment he had expe-
rienced 4 episodes of self-limiting polyarthralgia involving
his toes, ankles and fingers of over a period of two years.
Though he sought a medical attention, it was neither
treated nor followed up extensively due to its self-limiting
nature, lasting only a couple of days with mild swelling of
the involved joints. He reported complete remission since
surgery and ongoing treatment of infective endocarditis.
Gastroenteroscopic biopsy analysis was pre and post
operatively not necessary due to absent gastro intes-
tinal symptoms in our patient, in particular: no weight loss
Fig. 2 a–d: Whipple endocarditis in a 65- year- old patient. a/b. TEE displaying degenerative aortic valve with vegetations. b. Mild degenerative
aortic valve changes with pronounced edema, fibrin insudation and superficial collections of foamy macrophages (haematoxillin&eosin, 4x). d.
Demonstration of Pas-reactive foamy macrophages, which contained T. whipplei particles (Pas, 20x)
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or diarrhea was reported. Continued regular echocardio-
graphic and clinical check-ups remain imperative for this
patient.
Histopathology
Histologic examination of the submitted specimen
showed severely degenerative calcific valvular disease
with a chronic resorptive inflammation (Fig. 2c–d). With
PAS reagent, foamy macrophages with granular intracel-
lular PAS positive material, characteristic of T. whipplei
infection, were demonstrated (Fig. 2c–d).
Microbiology
DNA analysis performed as stated above revealed T.
whipplei as causative agent.
Discussion and literature review
Whipple’s disease is a rare chronic, often multisystemic
disease, which was first described by George Hoyt
Whipple in 1907 [9]. But, it was only after 1992 that
the causative agent, a rod-shaped, gram-positive bacter-
ium, Tropheryma whipplei, was identified by sequencing
its ribosomal RNA (rRNA) gene [10]. In spite of its bacter-
ial etiology, Whipple’s disease is a non-readily-contagious
condition, which mainly affects patients with a Th1/Th2
imbalance [2]. Chronic asymptomatic carriage of T. whip-
plei has been found in stool specimen of human, espe-
cially those exposed to sewage water [11]. However, the
infectious potential of Tropheryma whipplei is a moot
point [12]. There is evidence that person-to-person close
contacts either by faeco-oral or by oral to oral routes sup-
port bacterial transmission [13]. General hygiene practices
to prevent faeco-oral transmission are therefore highly
recommended for vulnerable population groups, since
predisposing immunologic or genetic factors would favour
development of Whipple’s disease in the long run [14, 15].
After contamination, patients may develop acute infection
with specific antibody response. Thereafter, two principal
ways of dealing with the infectious agent are envisioned:
patients displaying a strong immune response and har-
bouring specific antibodies for at least 5 years eventually
eliminate T. whipplei from their intestines, while patients
developing no or only a minor antibody response will suf-
fer from subacute or chronic infections, including classic
Whipple’s disease [16].
Whipple’s disease has a variable symptomology,
explainable by T. whipplei invasion into various tissues
and subsequent incorporation by tissue macrophages,
which are unable to eliminate the bacteria [4]. In Whip-
ple’s endocarditis, the infection is slowly progressive,
similar to that seen in Q fever and bartonellosis-induced
culture-negative endocarditis, and a prominent fibrosis
with mild chronic inflammation is seen histopathologically
[4]. In most cases, the cardinal features, i.e., diarrhea,
weight loss and arthralgia are present. However, in the
absence of this symptom-complex, diagnosis may be ex-
tremely difficult, elusive and delayed due to the absence of
an easily available and reliable serological or molecular
method to detect this microorganism in blood [17, 18].
Infective endocarditis during classical Whipple’s trio
(arthropathy, weight-loss and diarrhea) due to T. whipplei
is rare and its diagnosis could be difficult if it presents
without any prior history suggesting Whipple’s disease, in
which case blood cultures remain negative [18, 19]. Most
information on this entity has accrued from occasional
case reports and case series [18]. In fact, the prevalence of
infective endocarditis due to T. whippelei could be higher
in patients treated for culture-negative endocarditis [19].
In contrast to previous reports, Geiβdörfer et al. found T.
whipplei to be the fourth most frequent cause of bacterial
endocarditis (6.3 %) and the most frequent cause of
culture-negative endocarditis [18, 19]. Out of 16 patients
with Tropheryma whipplei endocarditis, 14 lacked gastro-
intestinal symptoms prior to surgical treatment [19]. Ac-
cording to Fenollar et al., the following characteristics may
aid in the recognition of possible Whipple associated in-
fective endocarditis in the absence of classical diag-
nostic criteria: T. whipplei endocarditis occurs mainly in
Caucasian men, who are about 50 years of age with cardial
symptoms such as heart failure, acute ischemic stroke and
peripheral arterial embolism [5]. These patients might
have complained about arthralgia for several years and
might have recently received immunosuppressants [5].
Arthralgia might be subtle and is only noticed after a
careful clinical investigation [5]. They strongly suggested
inquiring for the presence of arthralgia since the com-
bination of infective endocarditis and arthralgia suggests
T. whipplei infection [5]. This is in line with the history of
our first patient, as we observed a possible association be-
tween exposure to certain immune-modulatory agents
and exacerbation of otherwise under diagnosed Whipple’s
disease. Our patient had sero-negative rheumatoid arth-
ritis for approximately 15 years and only complained of
unintended weight loss over a period of 6 months prior to
diagnosis of infective endocarditis. No other symptoms
were recorded, until infective endocarditis struck. The sec-
ond patient reported none of the symptoms that would
suggest T. whipplei involvement in his ailment. However,
during follow up at 1-year post surgery, a comprehensive
interview revealed that the patient had a benign, self limit-
ing arthralgia, which was not medically attended to, due
to the subtle nature of his symptoms.
So far, little attention has been given to consequences
of T. whipplei infection exacerbation during therapy
with biological agents, a potentially fatal coincidence.
Table 1 presents reported cases and case series of patients
with symptoms initially misinterpreted until clinical dete-
rioration under various immune-modulatory agents,
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Table 1 Reports indicating alteration of the course of subacute Whipple’s disease during therapy with biological agents
Nr. Reports Indicating Potential Fatal Complications Of Biological Therapy During Sero-negative Rheumatoid Arthritis.
Author Journal Yr of Pub Nr. of
Pat.
Initial symptoms/Duration Therapy Results Conclusion/Finding
[20] Mahnel R. et al. Am. J. Gastroenterol. 2005 27 Immunosuppressiva lead to earlier
onset of diarrhea




Infliximab seems to increase the risk
of exacerbation of WD




Azathioprim/Prednison Chorioretinitis and Vitreitis Tropheryma whipplei DNA
in vitrous fluid and peripheral
blood
[23] Kremer AE. et al. Z. Gastroenterolog. 2008 1 SNRA/4 yrs Adalimumab/Leflunomid Septic fever severe
arthralgia weight loss
Immunmodulatory therapies, TNF
blockers and Corticosteroids may
lead to exercerbation of subacute,
undiagnosed Whipples Disease
[24] Spoerl D. et al. Orphanet. J. Rare Dis. 2009 1 Multisegment spondylitis TNF-a Worsening back pain TNF-a treatment worsened
spondylodiscitis, leading to
diagnosis of T. Whipplei from
rebiopsy of vertebral specimen





Corticosteroids 50 (43 %)
TNF-a antagonists 16 (14 %)




32 patients (28 %)
experienced aggravation




rheumatoid disease who experience
severe general involvment should
be screened for T. Whippelii or the
therapy is inneffective against
polyarthritis




worsened pre existing whipples
disease
[27] Vancsa A et al. Joint Bone Spine 2010 1 Seronegative
Oligoarthritis
Eternecept Endocarditis DMARDs resistant arthritis should
prompt thourough search T.whippelii
prior to initiation of TNF-a antagonists
[28] Hmamouci I et al. J. Rheumatol. 2010 1 Ankylosing spondylitis Eternecept Scurvy Eternecept probably modified the
cytokine environment and thus
favoured exercerbation of
whipples disease
[29] Daien C.I. et al. Rheumatology 2010 1 B-27- negative Ankylosing
spondylitis
Eternecept Endocarditis Report of the first case of t. Whippeliis
endocarditis, potentially induced by
TNF-a antagonist therapy
[30] Gaddy J.R. Rheumatology 2012 1 Back pain; Arthritis Various TNF a Inhibitors Fever, migratory arthritis Clinical deterioration despite TNF a
antagonists lead to thorough search














Table 1 Reports indicating alteration of the course of subacute Whipple’s disease during therapy with biological agents (Continued)








Whipples disease should be
suspected in patients with treated
with TNF a antagonists who do not
improve during inflammatory
rheumatism
[32] Marth T. World J. Cardiol. 2014 41vs
61vs1059
Arthritis TNF-a/41 patients 12.2 % vs 1.6 % vs
0.16 % endocarditis rates
TNF-a triggered severe whipples
disease complications particularly
endocarditis
[33] Marth T. Aliment. Pharmacol.
Ther.
2015 41 Arthritis, weight-loss,
Diarrhea





In case of doubt, Whipples
disease should be excluded














especially TNFα antagonists, facilitating a more fulminant
course of T. whipplei infection [20–33].
Conclusion
We strongly advocate intensive search for a potential oc-
cult Whipple’s disease in patients with therapy resistant
sero-negative rheumatoid arthritis prior to introduction
of immune modulatory therapies. T. whipplei should al-
ways be ruled out in patients who present with unex-
plained transient arthralgia irrespective of duration,
frequency and severity. Exacerbation of subacute Whip-
ple’s disease should be added to the list of possible side
effects of therapy with these agents, especially TNFα
antagonists.
Consent
Written informed consent was obtained from the pa-
tients for publication of the Case report and any accom-
panying images. A copy of the written consent is
available for review by the Editor of this journal.
Abbrevations
AS: Ankylosing spondylitis; CNS: Central nervous system; DMARD:
Disease-modifying anti rheumatic drugs; GIT: Gastrointestinal tract;
LN: Lymph node; NSAID: Non-steroidal anti-inflammatory drug;
pub: publication; RA: Rheumatoid arthritis; SA: Spondylarthritis;
SNRA: Seronegative rheumatoid arthritis; yr: year.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AA and AZ drafted the manuscript and collected clinical data. KK and AP
carried out microbiological analysis including PCR and sequencing analysis
and drafted part of the manuscript. BW and GS participated in coordination
and design of the study. AO and AE carried out the histological analysis and
participated in the design of the study. All authors read and approved the
final manuscript.
Acknowledgement
We thank Dr. B. Weiss and Dr. J. Wendeborn for taking care of the patients
both during their hospital-stay and follow up.
Author details
1Department of Cardiac Surgery, University Hospital Rostock, Schillingallee
35, 18057 Rostock, Germany. 2Institute of Pathology, University Hospital
Rostock, Strempelstr. 14, 18055 Rostock, Germany. 3Institute of Medical
Microbiology, Virology and Hygiene, University Hospital Rostock,
Schillingallee 70, 18055 Rostock, Germany.
Received: 2 May 2015 Accepted: 31 July 2015
References
1. Desnues B, Al Moussawi K, Fenollar F. New insights into Whipple`s disease
and Tropheryma whipplei infections. Microbes Infect. 2010;10:1102–10.
2. Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, et al. Dysregulated
peripheral and mucosal Th1/Th2 response in Whipple’s disease.
Gastroenterology. 2002;123:1468–77.
3. Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive
symptoms. Ann Thorac Surg. 1999;67:250–1.
4. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D.
Whipple’s disease: new aspects of pathogenesis and treatment. Lancet
Infect Dis. 2008;8:179–90.
5. Fenollar F, Célard M, Lagier J-C, Lepidi H, Fournier P-E, Raoult D.
Trophyeryma whipplei endocarditis. Emerg Infect Dis. 2013;19:1721–30.
6. Grijalva M, Horvath R, Dendis M, Cerny J, Benedik J. Molecular diagnosis of
culture negative endocarditis: clinical validation in a group of surgically
treated patients. Heart. 2003;89:263–8.
7. Zheng D, Alm EW, Stahl DA, Raskin L. Characterization of universal
small-subunit rRNA hybridization probes for quantitative molecular
microbial ecology studies. Appl Environ Microbiol. 1996;62:4504–13.
8. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA
amplification for phylogenetic study". J Bacteriol. 1991;173:697–703.
9. Whipple GH. A hitherto undescribed disease characterized anatomically by
depositis of fat and fatty acids in the intestinal and mesenteric lymphatic
tissues. John Hopkins Hosp Bull. 1907;18:382–91.
10. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the
uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.
11. Schöniger-Hekele M, Petermann D, Weber B, Müller C. Tropheryma whipplei
in the environment: survey of sewage plant influxes and sewage plant
workers. Appl Environ Microbiol. 2007;73:2033–5.
12. Fenollar F, Trape JF, Bassene H, Sokhna C, Raoult D. Tropheryma
whipplei in fecal samples from children. Senegal Emerg Infect Dis.
2009;15:922–4.
13. Keita AK, Brouqui P, Badiaga S, Benkouiten S, Ratmanov P, Raoult D, et al.
Tropheryma whipplei prevalence strongly suggests human transmission in
homeless shelters. Int J Infect Dis. 2013;17:e67–8.
14. Fenollar F, Trani M, Davoust B, Salle B, Birg ML, Rolain JM, et al. Prevalence
of asymptomatic Tropheryma whipplei carriage among humans and
nonhuman primates. J Infect Dis. 2008;197:880–7.
15. Ramharter M, Harrison N, Bühler T, Herold B, Lagler H, Lötsch F, et al.
Prevalence and Risk Factor Assessment of Tropheryma whipplei in a Rural
Community in Gabon: a Community Based Cross-Sectional Study. Clin
Microbiol Infect. 2014. doi:10.1111/1469-0691.12724.
16. Fenollar F, Keita AK, Buffet S, Raoult D. Intrafamilial circulation of
Tropheryma whipplei. France Emerg Infect Dis. 2012;18:949–55.
17. Freeman HJ. Tropheryma whipplei infection. World J Gastroenterol.
2009;15:2078–80.
18. Marín M, Muñoz P, Sánchez M, del Rosal M, Rodríguez-Créixems M, Bouza E.
Tropheryma whipplei infective endocarditis as the only manifestation of
Whipple’s disease. J Clin Microbiol. 2007;45:2078–81.
19. Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R,
et al. High frequency of Tropheryma whipplei in culture-negative
endocarditis. J Clin Microbiol. 2012;50:216–22.
20. Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T.
Immunosuppressive therapy in Whipple’s disease patients is associated with
the appearance of gastrointestinal manifestations. Am J Gastroenterol.
2005;100:1167–73.
21. Kneitz C, Suerbaum S, Beer M, Müller J, Jahns R, Tony HP. Exacerbation of
Whipple’s disease associated with infliximab treatment. Scand J Rheumatol.
2005;34:148–51.
22. Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomão DR, Walker RC.
Chorioretinitis and vitreitis due to Tropheryma whipplei after
transplantation: case report and review. Transpl Infect Dis. 2008;10:413–8.
23. Kremer AE, Budenhofer U, Beuers U, Rust C. A 47-year-old dog breeder with
chronic polyarthritis, weight loss and high fever. Z Gastroenterol.
2008;46:431–4.
24. Spoerl D, Bär D, Cooper J, Vogt T, Tyndall A, Walker UA. Multisegmental
spondylitis due to Tropheryma whipplei: case report. Orphanet J Rare Dis.
2009;4:13. doi:10.1186/1750-1172-4-13.
25. Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei:
clinical presentation of 142 patients with infections diagnosed or confirmed
in a reference center. Medicine (Baltimore). 2010;89:337–45.
26. Hoppé E, Masson C, Audran M, Drillon M, Andreu M, Saraux A, et al.
Whipple’s disease diagnosed during biological treatment for joint disease.
Joint Bone Spine. 2010;77:335–9.
27. Ansemant T, Celard M, Tavernier C, Maillefert JF, Delahaye F, Ornetti P.
Whipple’s disease endocarditis following anti-TNF therapy for atypical
rheumatoid arthritis. Joint Bone Spine. 2010;77:622–3.
28. Hmamouchi I, Costes V, Combe B, Morel J. Scurvy as the presenting illness
of Whipple’s disease exacerbated by treatment with etanercept in a patient
with ankylosing spondylitis. J Rheumatol. 2010;37:1077–8.
29. Daïen CI, Cohen JD, Makinson A, Battistella P, Bilak EJ, Jorgensen C, et al.
Whipple’s endocarditis as a complication of tumour necrosis factor-alpha
Alozie et al. BMC Infectious Diseases  (2015) 15:339 Page 8 of 9
antagonist treatment in a man with ankylosing spondylitis. Rheumatology
(Oxford). 2010;49:1600–2.
30. Gaddy JR, Khan ZZ, Chaser B, Scofield RH. Whipple's disease diagnosis
following the use of TNF-α blockade. Rheumatology (Oxford). 2012;51:946.
31. Sparsa L, Fenollar F, Gossec L, Leone J, Pennaforte JL, Dougados M, et al.
Whipple disease revealed by anti-TNFα therapy]. Rev Med Interne.
2013;34:105–9.
32. Marth T. Complicated Whipple’s disease and endocarditis following tumor
necrosis factor inhibitors. World J Cardiol. 2014;6:1278–84.
33. Marth T. Systematic review: Whipple’s disease (Tropheryma whipplei
infection) and its unmasking by tumour necrosis factor inhibitors.
Aliment Pharmacol Ther. 2015;41:709–24.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alozie et al. BMC Infectious Diseases  (2015) 15:339 Page 9 of 9
